Advances in the Development of Biotherapeutics
نویسندگان
چکیده
1 Institut Pasteur, Microbial Evolutionary Genomics, Département Génomes et Génétique, Paris, France 2CNRS, UMR3525, Paris, France 3Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria 4enGenes Biotech GmbH, Vienna, Austria 5Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras, Portugal 6Instituto de Tecnologia Quı́mica e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal 7Departamento de Procesos y Tecnologı́a, Universidad Autónoma Metropolitana-Cuajimalpa, Delegación Álvaro Obregón, Mexico 8Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK
منابع مشابه
Recent Advances in Biotherapeutics Drug Discovery and Development
Biotherapeutics drugs, such as antibodies, Fc-like fusion proteins, and therapeutic replacement enzymes, constitute the most rapidly growing drug class, and have become a major clinical success of human therapeutics over the past decade. These therapeutics of large-molecule have revolutionized the treatment of a variety of diseases in areas such as oncology, inflammatory and autoimmune diseases...
متن کاملIn vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
Objective(s): Lung cancer is the main leading cause of cancer death worldwide. Angiogenesis is the main step in proliferation and spreading of tumor cells. Targeting vascular endothelial growth factor (VEGF) is an effective approach for inhibition of cancer angiogenesis. Nanobodies (NBs) are a novel class of antibodies derived from the camel. Unique characteristics of Nbs like their small size ...
متن کاملIn vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies
Objective(s): Emergence of resistant tumor cells to the current therapeutics is the main hindrance in cancer treatment. Combination therapy, which mixes two or more drugs, is a way to overcome resistant problems of cancer cells to current treatments. Nanobodies are promising tools in cancer therapy due to their high affinity as well as high penetration to tumor sites....
متن کاملDmd058917 1858..1866
Remarkable methodological advances in the past decade have expanded the application of liquid chromatography coupled with mass spectrometry (LC/MS) analysis of biotherapeutics. Currently, LC/MS represents a promising alternative or supplement to the traditional ligand binding assay (LBA) in the pharmacokinetic, pharmacodynamic, and toxicokinetic studies of protein drugs, owing to the rapid and ...
متن کاملRecent Advances in Glycosylation Modifications in the Context of Therapeutic Glycoproteins
Glycosylation is one of the most complex post-translation modifications, commonly found in many cell surface and secreted eukaryotic proteins. 1-2% of the human transcriptome encodes proteins that link to glycosylation. Many protein-based biotherapeutics approved or in clinical trials are glycoproteins. The oligosaccharides covalently attached to therapeutic glycoproteins pose biological benefi...
متن کاملGut microbiota: next frontier in understanding human health and development of biotherapeutics
The gut microbiota is a remarkable asset for human health. As a key element in the development and prevention of specific diseases, its study has yielded a new field of promising biotherapeutics. This review provides comprehensive and updated knowledge of the human gut microbiota, its implications in health and disease, and the potentials and limitations of its modification by currently availab...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
دوره 2015 شماره
صفحات -
تاریخ انتشار 2015